+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stada Arzneimittel AG - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 41 Pages
  • January 2025
  • GlobalData
  • ID: 5116248
Stada Arzneimittel AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Stada Arzneimittel AG (STADA), a subsidiary of Nidda Healthcare GmbH, is a manufacturer of low-cost generics and branded over-the-counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. The company offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin and Epoetin zeta. Its major branded products include APO-Go, Grippostad, Snup and Fultium. The company operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.

Stada Arzneimittel AG Key Recent Developments

  • Oct 31, 2024: New STADA Facility in Romania for Sustainable Medicines Supply in Europe
  • Jun 24, 2024: STADA Health Report 2024: Satisfaction with healthcare systems continues to decline
  • Mar 14, 2024: STADA continues with double-digit sales and profit growth in 2023
  • Jan 09, 2024: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Stada Arzneimittel AG - Key Facts
  • Stada Arzneimittel AG - Key Employees
  • Stada Arzneimittel AG - Key Employee Biographies
  • Stada Arzneimittel AG - Major Products and Services
  • Stada Arzneimittel AG - History
  • Stada Arzneimittel AG - Company Statement
  • Stada Arzneimittel AG - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Stada Arzneimittel AG - Business Description
  • Product Category: Consumer Healthcare
  • Overview
  • Performance
  • Product Category: Generics
  • Overview
  • Performance
  • Product Category: Specialty
  • Performance
  • R&D Overview
  • Stada Arzneimittel AG - Corporate Strategy
  • Stada Arzneimittel AG - SWOT Analysis
  • SWOT Analysis - Overview
  • Stada Arzneimittel AG - Strengths
  • Stada Arzneimittel AG - Weaknesses
  • Stada Arzneimittel AG - Opportunities
  • Stada Arzneimittel AG - Threats
  • Stada Arzneimittel AG - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Stada Arzneimittel AG, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Oct 31, 2024: New STADA Facility in Romania for Sustainable Medicines Supply in Europe
  • Jun 24, 2024: STADA Health Report 2024: Satisfaction with healthcare systems continues to decline
  • Mar 14, 2024: STADA continues with double-digit sales and profit growth in 2023
  • Jan 09, 2024: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Section 5 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Stada Arzneimittel AG, Key Facts
  • Stada Arzneimittel AG, Key Employees
  • Stada Arzneimittel AG, Key Employee Biographies
  • Stada Arzneimittel AG, Major Products and Services
  • Stada Arzneimittel AG, History
  • Stada Arzneimittel AG, Subsidiaries
  • Stada Arzneimittel AG, Key Competitors
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Stada Arzneimittel AG, Recent Deals Summary
List of Figures
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Stada Arzneimittel AG, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • MorphoSys AG
  • MediGene AG
  • Evotec SE
  • EGIS Pharmaceuticals Plc
  • MPA Pharma GmbH
  • Biotest AG